Commonly assessed biological markers used to evaluate the subtype of breast cancer include hormone receptor (HR), also referred to as estrogen receptor/progesterone receptor (ER/PR), and human epidermal growth factor receptor-2 (HER2) protein [26]. Here, ERBB2 is linked to breast carcinoma.